Research Paper Volume 12, Issue 22 pp 23096—23113

Protective effect of DLX6-AS1 silencing against cerebral ischemia/reperfusion induced impairments

Figure 2. DLX6-AS1 silencing ameliorated long-term neurological dysfunction after ischemia. (A) the escape latency, (B) representative image and statistical evaluation of the Morris water maze and the target quadrant time tests (C) the pole test, (D) photomicrograph (cresyl violet stain) and statistical chart showing the regions of the cortex, corpus callosum, hippocampus, and midbrain of the brain. Values represent mean ± SEM (n = 6 in each group). *P < 0.05, **P < 0.01, ***P < 0.001 vs sham; +P < 0.05, ++P < 0.01 vs + LV-NEG-shRNA.